Inspection Record

Liberchem Inc. — Health Canada Inspection Findings

Health CanadaInspected 2021-08-09 10 findingsOther quality systemLaboratory and QC controlsRegulatory reporting and change controlStability and storageQuality unit oversightEquipment and facilityLabeling and packagingMaterial and supplier control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

2Laboratory and QC controls

The education, experience, and/or oversight of the individual in charge of the quality control department was inadequate. The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

3Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

4Stability and storage

The changes made to the stability study of a drug were not scientifically justified.

5Quality unit oversight

The annual product quality review procedure was inadequate.

6Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

7Other quality system

Critical production processes were not validated. The master formula for packaged products did not include the required information.

8Stability and storage

The temperature and/or humidity control was inadequate.

9Labeling and packaging

The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).

10Material and supplier control

The availability and/or the content of the written agreement between the raw material vendor and the drug fabricator was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-08-09. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Liberchem Inc. company profile — full history Health Canada documents, 2021 Go to Findings search